Dobashi et al.24evaluated changes and activation of EGFR and EGFR-mediated signaling cascade in 31 sarcomas and malignant bone tumors compared to 8 benign lesions of mesenchymal origin by immunohistochemical analysis, FISH, Western blot, and nucleotide analysis. This evidence concerns the gene EGFR and sarcoma.